Company intelligence / Profile preview

Cannamedical Pharma

Köln, Nordrhein-Westfalen, Germany

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Cannamedical Pharma is a commercial-stage German pharmaceutical wholesaler focused on importing, processing, and distributing EU‑GMP medicinal cannabis products under its own brand to pharmacies and clinical facilities in Germany and across Europe.[1][2][3][4]

Therapeutic areas: NeurologyOther
Modalities: Plant-derived product
Industry: Biotech

Drug pipeline

4 assets

Afghan Bubba Kush

Unknown

3 more assets in the full pipeline.

Request access →

Partnerships

Multiple international EU‑GMP medicinal cannabis flower and extract suppliers across three continents (nine supply agreements reported as of 2019).

Beyond the preview

Go deeper on Cannamedical Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cannamedical Pharma.

Explore the full profile